Daniel Onofre Vidal

Dr. Daniel Onofre Vidal

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2007 in Genome Biology
Verified
Journal Article
Open access
PDF file
PEDRO A F GALANTEPEDRO A F GALANTE
PEDRO A F GALANTE
DVDaniel Onofre Vidal
Daniel Onofre Vidal
JSJorge E de Souza
Jorge E de Souza
ACAnamaria Camargo
Anamaria Camargo
SSSandro J de Souza
Sandro J de Souza
Background: A significant number of genes in mammalian genomes are being found to have natural antisense transcripts (NATs). These sense-antisense (S-AS) pairs are believed to be involved in several cellular phenomena. Results: Here, we generated a catalog of S-AS pairs occurring in the human and mouse genomes by analyzing different sources of expressed sequences available in the public domain plus 122 massively parallel signature sequencing (MPSS) libraries from a variety of human and mouse tissues. Using this dataset of almost 20,000 S-AS pairs in both genomes we investigated, in a computational and experimental way, several putative roles that have been assigned to NATs, including gene expression regulation. Furthermore, these global analyses allowed us to better dissect and propose new roles for NATs. Surprisingly, we found that a significant fraction of NATs are artifacts produced by genomic priming during cDNA library construction. Conclusion: We propose an evolutionary and functional model in which alternative polyadenylation and retroposition account for the origin of a significant number of functional S-AS pairs in mammalian genomes.

1 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CMCamila Maria da Silva Martinelli
Camila Maria da Silva Martinelli
ALAndré van Helvoort Lengert
André van Helvoort Lengert
FCFlavio Carcano
Flavio Carcano
ESEduardo Caetano Albino Silva
Eduardo Caetano Albino Silva
MBMariana Brait
Mariana Brait
DVDaniel Onofre Vidal
Daniel Onofre Vidal
MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients

2 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VUVanessa Regina Maciel Uzan
Vanessa Regina Maciel Uzan
ALAndré van Helvoort Lengert
André van Helvoort Lengert
ÉBÉrica Boldrini
Érica Boldrini
VPValter Penna
Valter Penna
CSCristovam Scapulatempo-Neto
Cristovam Scapulatempo-Neto
DVDaniel Onofre Vidal
Daniel Onofre Vidal
Osteosarcoma (OS) is the most common primary bone cancer in childhood. OS is an aggressive disease, and metastatic patients evolve with very poor clinical outcomes. Genetically, OSs are extremely complex tumors, and the related metastatic process is not well understood in terms of the biology of the disease. In this context, long non-coding RNAs (lncRNAs) have emerged as an important class of gene expression regulators that play key roles in the invasion and metastasis of several human tumors. Here, we evaluated the expression of HULC, which is an lncRNA that is associated with the tumor metastatic process, and assessed its potential role as a prognostic marker in OS. HULC expression was evaluated in primary OS samples using real-time RT-PCR. HULC expression status was determined by receiver operating characteristic (ROC) analysis, and its association with survival was assessed using the Kaplan-Meier method. The HULC expression level was not significantly associated with the clinicopathological characteristics of the OS patients. However, our data demonstrated that higher levels of expression of HULC were associated with lower survival rates in OS patients, both in terms of overall and event-free survival. Elevated HULC expression was associated with poor clinical outcomes among the OS patients, which suggests that HULC could be a potential prognostic biomarker in OS.

30 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BMBruna Rodrigues Muys
Bruna Rodrigues Muys
JLJúlio Cesar Cetrulo Lorenzi
Júlio Cesar Cetrulo Lorenzi
DZDalila Luciola Zanette
Dalila Luciola Zanette
RBRafaela de Barros Lima e Bueno
Rafaela de Barros Lima e Bueno
LALuíza Ferreira de Araújo
Luíza Ferreira de Araújo
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
LINC00629 and MIR503HG are long intergenic non-coding RNAs (lincRNAs) mapped on chromosome X (Xq26), a region enriched for genes associated with human reproduction. Genes highly expressed in normal reproductive tissues and cancers (CT genes) are well known as potential tumor biomarkers. This study aimed to characterize the structure, expression, function and regulation mechanism of MIR503HG and LINC00629 lincRNAs. According to our data, MIR503HG expression was almost exclusive to placenta and LINC00629 was highly expressed in placenta and other reproductive tissues. Further analysis, using a cancer cell lines panel, showed that MIR503HG and LINC00629 were expressed in 50% and 100% of the cancer cell lines, respectively. MIR503HG was expressed predominantly in the nucleus of JEG-3 choriocarcinoma cells. We observed a positively correlated expression between MIR503HG and LINC00629, and between the lincRNAs and neighboring miRNAs. Also, both LINC00629 and MIR503GH could be negatively regulated by DNA methylation in an indirect way. Additionally, we identified new transcripts for MIR503HG and LINC00629 that are relatively conserved when compared to other primates. Furthermore, we found that overexpression of MIR503HG2 and the three-exon LINC00629 new isoforms decreased invasion and migration potential of JEG-3 tumor cell line. In conclusion, our results suggest that lincRNAs MIR503HG and LINC00629 impaired migration and invasion capacities in a choriocarcinoma in vitro model, indicating a potential role in human reproduction and tumorigenesis. Moreover, the MIR503HG expression pattern found here could indicate a putative new tumor biomarker.

1 September 2009 in Oral Oncology
Verified
Journal Article
Closed access
EOEloisa Helena Ribeiro Olivieri
Eloisa Helena Ribeiro Olivieri
SSSabrina Daniela da Silva
Sabrina Daniela da Silva
FMFernando Fernandes Mendonça
Fernando Fernandes Mendonça
YUYuri Nagamine Urata
Yuri Nagamine Urata
DVDaniel Onofre Vidal
Daniel Onofre Vidal
SRSilvia Rogatto
Silvia Rogatto

1 February 2007 in Leukemia Research
Verified
Journal Article
Closed access
DVDaniel Onofre Vidal
Daniel Onofre Vidal
VPValéria A. Paixão
Valéria A. Paixão
MBMariana Brait
Mariana Brait
ESElisabeth X. Souto
Elisabeth X. Souto
OCOtávia L. Caballero
Otávia L. Caballero
AVAndré L. Vettore
André L. Vettore